pilocarpine hydrochloride · Orasis Pharms · NDA 217836
Qlosi
Earliest generic entry, as listed
18 Aug 2037
Blocked by patent: US 10639297, US 11129812, US 11974986, US 9867810.
Listed patents · 4 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 10639297 | drug product, use U-3741 · sets the listed date | 18 Aug 2037 |
| US 11129812 | use U-3741 · sets the listed date | 18 Aug 2037 |
| US 11974986 | use U-3741 · sets the listed date | 18 Aug 2037 |
| US 9867810 | drug product, use U-3741 · sets the listed date | 18 Aug 2037 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 217836 · 001 · RLD | solution/drops, ophthalmic | 0.4% | 18 Aug 2037 |
Expired or delisted (1)
- NP · 17 Oct 2026